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Fast eradication of mature biofilms is the ‘holy grail’ in the clinical management of device-
related infections. Endogenous nitric oxide (NO) produced by macrophages plays an
important role in host defense against intracellular pathogens, and NO is a promising
agent in preventing biofilms formation in vitro. However, the rate of delivery of NO by
various NO donors (e.g., diazeniumdiolates, S-nitrosothiols, etc.) is difficult to control,
which hinders fundamental studies aimed at understanding the role of NO in biofilm
control. In this study, by using a novel precisely controlled electrochemical NO releasing
catheter device, we examine the effect of physiological levels of NO on eradicating
mature Pseudomonas aeruginosa biofilm (7 days), as well as the potential application of
the combination of NO with antimicrobial agents. It is shown that physiological levels of
NO exhibit mixed effects of killing bacteria and dispersing ambient biofilm. The overall
biofilm-eradicating effect of NO is quite efficient in a dose-dependent manner over a 3 h
period of NO treatment. Moreover, NO also greatly enhances the efficacy of antimicrobial
agents, including human beta-defensin 2 (BD-2) and several antibiotics, in eradicating
biofilm and its detached cells, which otherwise exhibited high recalcitrance to these
antimicrobial agents. The electrochemical NO release technology offers a powerful tool
in evaluating the role of NO in biofilm control as well as a promising approach when
combined with antimicrobial agents to treat biofilm-associated infections in hospital
settings, especially infections resulting from intravascular catheters.
Keywords: nitric oxide, antimicrobial agents, combination, biofilms, Pseudomonas aeruginosa, antimicrobial
peptide, antibiotics
INTRODUCTION
Implanted medical devices are frequently used in hospitals for therapeutic and diagnostic purposes.
However, the use of many of these devices, especially indwelling ones such as intravascular
catheters, are often associated with increased risk of infection (Donlan, 2001). Antibiotic lock
solutions and systemic usage of antibiotics is a common clinical practice (Del Pozo et al., 2012),
but biofilm can still form on the devices, and the rate of treatment failure can reach 50% depending
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on the factors of the pathogens and the host (Baldassarri et al.,
2006). Once the biofilm matures (>96 h), the bacteria in the
biofilm show severe recalcitrance to antibiotic treatment as
most antibiotics target planktonic bacteria rather than those in
the biofilm (Wolcott et al., 2010). Many studies have focused
on the prevention of biofilm formation by obstructing the
initial attachment, either by coating antibiotic on the surface
or by modifying the physio-chemical properties of the surface
(Hasan et al., 2013). However, these strategies fail to stop the
biofilm formation completely as the desired surface property can
be dramatically masked or changed in the clinical setting. In
addition, many prevention strategies rely on sustained treatment,
which adds additional pain and medical cost to the patients.
Strategies to eradicate mature biofilm on medical devices
are considered the “holy grail” in controlling biofilm-related
infections.
To address the problem of mature biofilms on devices,
various strategies including use of biofilm-breaking enzymes
(Chaignon et al., 2007), quorum sensing agents (Cirioni et al.,
2006), and bacteriophages (Hughes et al., 1998) have been
attempted. However, they suffer from being restricted to a
spectrum of microbes on which they are effective, as well as
the potential for toxicity or immune response in vivo. To
circumvent these limitations, nitric oxide (NO) is attractive as
it is endogenously produced and participates in the human
host defense system. Various polymeric materials capable of
NO release at 0.5–4.0 × 10−10 mol cm−2 min−1 (0.5–4.0 flux)
have been developed over the past two decades because this
range is considered physiologically relevant and safe (Vaughn
et al., 1998; Frost et al., 2005; Carpenter and Schoenfisch, 2012).
However, the effectiveness of NO in this frequently targeted
range on mature biofilm is not entirely clear. In most cases, NO
starts to release as soon as the materials are introduced to the
bacteria, demonstrating the prevention of biofilm rather than the
eradication of mature biofilm.
To study the effect of NO on mature biofilm, the direct use
of NO donors on mature biofilm has received some attention
(Barraud et al., 2006, 2009a,b; de la Fuente-Nunez et al., 2013;
Alexander et al., 2015); however, the observed effect of NO is
often influenced by the high concentration of NO donors in the
media (up 1000× greater than NO). Hence, the organic portion
of the donor and its degradation product can contribute to the
observed effect (Feelisch, 1998; Frost et al., 2005). In addition,
the release of NO from donors in the medium is less controlled
and is strongly influenced by the medium composition, including
pH, ionic strength and even trace amount of metal ions (Wang
et al., 2002; Frost et al., 2005; Harding and Reynolds, 2014).
Therefore, it is desirable to elucidate the quantitative effect of NO
on mature bacterial biofilms via a predictable and controllable
NO release system, without exposing the bacteria to NO prior to
biofilm formation, as well as to any organic NO donor molecule
or associated product species after NO release.
In addition, the fate of NO treated bacteria and the interaction
of NO release with host defense and routinely applied antibiotics
are also critical for the application of any NO release technique
in future medical devices. Previous studies on the utility of
NO on the efficacy of antibiotics have yielded mixed results
(Barraud et al., 2009b; Gusarov et al., 2009; Privett et al., 2010;
McCollister et al., 2011; Zemke et al., 2015). Therefore, any
potential synergistic effects between NO and endogenous and
exogenous antimicrobial agents needs careful investigation.
A recently developed electrochemical NO release catheter
(Ren et al., 2014) provides an ideal tool for these studies. In
this system, NO can be released on demand from the surface of
a catheter or other device with highly tunable and predictable
fluxes, free from the interference of any organic NO donor
structures that could also affect the bacteria. Using this NO
release model, the prevention of biofilm formation has been
demonstrated (Ren et al., 2014, 2015). In the current study, we
further establish the dosage effects of physiological levels of NO
release on eradicating mature Pseudomonas aeruginosa biofilm
using the electrochemical NO release catheter. The potential
application of the combination of NO release with antibacterial
agents is also evaluated. The goal is to eradicate detached cells
from biofilms to prevent dispersal of bacterial cells to other
sites causing secondary infections. Our approach is that by
disrupting bacterial biofilms into dispersed bacterial cells via NO
treatment, these bacteria can be further eradicated by the human
immune system or conventional antibiotics, which would offer
a new therapeutic approach for disease treatment (Bordi and de
Bentzmann, 2011).
MATERIALS AND METHODS
Catheter Fabrication and NO Release
Profile Measurements
The catheter fabrication procedures used were similar to those
reported previously (Ren et al., 2014, 2015). A single lumen
silicone tube (o.d. 1.96 mm, i.d. 1.47 mm) was cut into 6 cm
lengths, and each piece was sealed at one end with silicone rubber
adhesive (3140 RTV, Dow-Corning, Midland, MI, USA). The
lumen was filled with a solution containing 4 mM copper(II)-
tri(2-pyridylmethyl)amine, 0.4 M NaNO2, 0.2 M NaCl, and 0.5 M
HEPES buffer (pH 7.2). A Teflon-coated Pt wire (3 cm exposed)
and a Ag/AgCl wire (5 cm exposed) were inserted into the lumen
as the working and reference/counter electrodes, respectively.
The opening of the lumen at the proximal end was then sealed
(around the wires) with silicone rubber adhesive and left to cure
in water overnight (see Figure 1). The NO release profile of
the catheters was tested by applying different voltages, and the
NO flux from the surface of the catheters was quantitated using
a NO chemiluminescence analyzer (Sievers 280i, GE Analytics,
Boulder, CO, USA), as reported previously (Zheng et al., 2015).
Bacterial Strain and Biofilm Growth
Pseudomonas aeruginosa PAO1 wild-type strain was obtained
from University of Washington (UW Genome Sciences, Seattle,
WA, USA; Winsor et al., 2011). The bacterial strain was
maintained on a Luria Bertani (LB) agar plate and grown in
LB broth. Biofilms were developed on the outer surface of the
catheter tubing in a CDC bioreactor (BioSurface Technologies,
Bozeman, MT, USA) supplemented with 10% strength of LB
broth. Briefly, the electrochemical NO release catheters were
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FIGURE 1 | Schematic of the electrochemical NO releasing catheter
employed in this study, with a cutaway view showing the inner
electrodes of the catheter that are capable of creating NO from
inorganic nitrite via electrochemical reduction reaction mediated by a
Cu(II)-ligand complex.
mounted on the holders within the CDC bioreactor. Four mL
of overnight grown P. aeruginosa PAO1 culture were inoculated
into the CDC bioreactor at final concentration about 106
CFU/mL, and the CDC bioreactor was left static for 1 h before
introducing fresh 10% LB media at 100 mL/h via a peristaltic
pump and starting the magnetic stirrer to generate shear force
(300 rpm, ∼0.08 N m−2; Goeres et al., 2005). The biofilms
were allowed to develop on the surface of the catheters in the
bioreactor for 7 days (d) at 37◦C, and the catheter pieces were
then taken out aseptically from the reactor and gently rinsed in
sterile PBS to remove any loosely attached bacteria. The catheters
were then subjected to further studies.
Dosage Effect of NO on 7-day Biofilms
Disruption
The catheters with 7-day biofilms were transferred into 5 mL
of PBS in a 15-mL centrifuge tube. The wires of the catheters
were connected to a multi-channel potentiostat (1000C, CH
Instrument, Austin, TX, USA), with the platinum wire connected
to the working electrode lead, and the silver wire to the reference
and counter leads. The NO release was then turned “on” for
3 h by applying the voltages required to achieve the flux desired
at the outer surface of the catheters (e.g., −0.22 V for 0.3 flux,
−0.23 V for 0.5 flux, −0.275 V for 1.5 flux, and −0.325 V for
3.0 flux; Ren et al., 2014). The solution remained static during
the dispersal experiment (Figure 2A). After 3 h of NO release,
the viable bacterial cells remaining on the catheter surfaces were
quantified by plate counts. Briefly, the catheters were taken out
of the PBS, and the inner filling solutions of the catheters were
carefully removed using a syringe from the proximal end of
the catheters. A 3 cm piece of the catheter was cut off and put
into a 2 mL fresh PBS and treated with a homogenizer (Omni
International, Kennesaw, GA, USA) at the highest speed for 1 min
to remove and homogenize the biofilm from the catheter surface
into PBS. The homogenate was 10-fold serially diluted with PBS,
and 50 µL of each dilution was plated onto LB agar plates, that
were incubated overnight at 37◦C for the colony-forming unit
(CFU) counting.
The bacteria released to the buffer during the 3 h NO release
experiment were also quantified similarly as described above. The
buffer was homogenized before serial dilutions and plate counts.
The catheter samples at each flux level were tested in triplicate,
and the Student’s t-test was used for statistical analysis. The total
viable bacterial number of the biofilm was calculated by adding
the number of bacteria on the catheter and the number of bacteria
in the buffer.
Susceptibility of P. aeruginosa Biofilm to
Antimicrobial Agents Combined with NO
Release
The procedures were similar to those of the dosage study
described above. The 7 days biofilm attached catheters were
placed in PBS containing 20 µg/mL of beta-defensin 2
(BD-2), or 100 µg/mL of antibiotic. The antibiotics examined
included colistin, gentamicin, chloramphenicol, ciprofloxacin
and tetracycline (n = 3 catheters for each condition). NO was
turned “on” at 1.5 flux immediately after the catheters were
introduced to the buffer containing the antimicrobial agents.
Catheters without turning “on” the NO release were used as
controls. After a 3 h incubation, the bacteria remaining on the
catheter surfaces as well as those dispersed in the buffer were
quantified by plate counting as described above.
Susceptibility of P. aeruginosa Released
Cells From Biofilms to Antimicrobial
Agents Combined with NO Release
To further confirm the increased susceptibility of the biofilm-
detached cells, another set of catheters with pre-developed
biofilms were placed in PBS without gentamicin/NO for 3 h
to let the biofilm bacteria shed naturally. The PBS was then
homogenized as described above and treated with gentamicin
at various concentrations (0–500 µg/mL) in the presence and
absence of NO for 3 h. Viable bacteria in buffer were enumerated
by plate counting. Experiments were performed in triplicate.
Statistical Methods
All data were presented as the mean value with their standard
deviation of replicates of different biological samples with n = 3.
The geometric mean was used for the log transformation of
the bacterial plate counting data. Student’s t-test was used for
calculating the confidence intervals and significance. p-values
were calculated from t distribution with degree of freedom of 2.
RESULTS
Physiological Levels of NO Effectively
Eradicated 7 days P. aeruginosa Biofilm
To study the effect of physiological levels of NO on mature
biofilm, P. aeruginosa biofilm was allowed to develop on the
surface of the catheters for 7 days before NO was turned “on”
(NO release profile demonstrated in Supplementary Figure S1).
As shown in Figure 2B, 3 h of NO release at 1.5 flux induced
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FIGURE 2 | (A) Illustration of the experimental procedure used in this study; (B) representative images of NO release catheter surface and its biofilm at 0 and 3 h. NO
release from the surfaces of the catheters at a flux of 1.5 × 10−10 mol cm−2 min−1; (C) representative images of biofilm on control catheters at 0 and 3 h. Green
dash line indicates the edge of biofilm. Black arrow shows the location of biofilm.
removal of mature biofilms from the catheter surface. While
the biofilm remained intact on the control catheter’s surface
(Figure 2C). To further evaluate the overall eradicating effect,
each of the catheters with pre-developed P. aeruginosa biofilms
was transferred into separate PBS solutions. Different levels of
NO were then turned “on” for 3 h, and the viable bacteria on the
catheter surfaces (in biofilms) and those detached/dispersed into
the buffer were quantified by the plate counting methods. From
Figure 3, it can be seen that there were significant levels of viable
bacteria within the 7-days biofilm and it naturally dispersed cells
(about 1% of total biofilm cells) from biofilm matrix to the nearby
buffer solution. When NO was turned on, at only 0.3 flux, the NO
release already showed a significant biofilm eradicating effect by
reducing 86% of the viable biofilm on the surface.
The biofilm eradicating effect was positively correlated with
NO flux and reached a 3-log reduction when the NO flux was
>1.5 (see Figure 3 and Table 1). As for the cells in the nearby
buffer, the NO showed the same trend as observed for its effect
on the surface biofilm, except when NO was at the flux of 0.3,
it increased the number of dispersed cells in buffer than biofilm
naturally dispersed (87%) and the difference was close to being
significant (p = 0.06). This result indicates that the effect of NO
on biofilm is a mixed process, with both killing and dispersal
effects. The total viable cells (the sum of the viable bacteria on the
catheter surface and those dispersed into the buffer) decreased
with an increase in NO release flux. More than a 1-log reduction
of the total viable cells was observed in 3 h when the NO was
above 0.5 flux, and a 2-log reduction was found when NO was
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FIGURE 3 | Dosage effects of 3 h NO release on 7-day P. aeruginosa
biofilms. Viable bacteria were measured both on the surface of catheters and
in the buffer after NO turned “on” for 3 h at room temperature. Asterisk
denotes statistical significance at each flux compared with corresponding 0
flux (n = 3 catheters for each flux, n.s.: no significance, ∗p < 0.05;
∗∗p < 0.01, ∗∗∗p < 0.001).
TABLE 1 | Effect of NO flux on dispersing and killing of 7-day
Pseudomonas aeruginosa biofilm.†
NO flux/10−10 mol cm−2 min−1 0 0.3 0.5 1.5 3.0
Attached viable cells 96.5% 13.4% 0.8% 0.1% 0.1%
Detached viable cells 3.5% 6.6% 2.2% 1.4% 0.5%
Total viable cells 100.0% 20.0% 2.9% 1.6% 0.5%
†The data is normalized to total viable cell from control (0 flux of NO). Total viable
cells are calculated by adding the number of viable cells on the catheter (CFU/cm2
multiplied by the surface area of the catheter) and those in the buffer (CFU/mL
multiplied by the volume of buffer).
at 3.0 flux, indicating the significant killing effect of physiological
levels of NO on biofilms. However, only a modest killing effect
(reduction within 1 log) was observed when NO was turned “on”
to treat the bacteria in the buffer. This is likely due to the short
half-life of NO as it diffuses out into the surrounding solution,
owing to its reaction with oxygen.
NO Increases Susceptibility of
P. aeruginosa Biofilm to Endogenous and
Exogenous Antimicrobial Agents
Since NO at physiological levels showed a significant killing
effect on the biofilm cells, the interaction of NO with other
antimicrobial agents was also evaluated. We first studied the
combination of NO and BD-2, as BD-2 is an important
endogenous antimicrobial peptide in human host defense. In
the absence of NO, the biofilm showed recalcitrance (<1 log
reduction) to BD-2 (see Figure 4). Interestingly, NO showed a
strong enhancing effect with BD-2 (at 20 µg/mL) in eradicating
pre-developed P. aeruginosa biofilm. The combination of NO
release at 1.5 flux and BD-2 can induce 4-log reduction in 3 h.
Similarly, a significant enhancing effect of NO release
on antibiotic activity was observed for gentamicin, colistin,
chloramphenicol, ciprofloxacin and tetracycline, when each was
present at 10 µg/mL. In the absence of NO release, P. aeruginosa
FIGURE 4 | Efficacy of 3 h treatment of BD-2 and various antibiotics
against 7-day P. aeruginosa biofilm in the absence and presence of
NO release. The concentration of BD-2 is 20 µg/mL, and concentration for
all other antibiotics is 100 µg/mL. NO release is 1.5 flux. Asterisk denotes
statistical significance compared with the control samples (n = 3 catheters for
treatment, n.s., no significance, ∗p < 0.05; ∗∗p < 0.01, ∗∗∗p < 0.001).
biofilm showed significant recalcitrance to all the antibiotics at
100 µg/mL. When NO was turned “on” at 1.5 flux, the biofilm
cells became much more susceptible to antibiotics, resulting
>3 log reduction of viable biofilms counts in 3 h for all the
antibiotics (see Figure 4). For colistin and chloramphenicol,
biofilm was completely eradicated in 3 h when combined with
NO release (viable cells are below the detection limit for plate
counting method, <10 CFU/mL). The combination of each
antibiotic with NO showed a significantly greater reduction
in viable biofilm cells than NO or gentamicin acting alone or
even their sum, indicating a significant enhancing effect of NO
on the efficacy of antibiotics against biofilms (Supplementary
Table S1).
NO Increases Susceptibility of
P. aeruginosa Biofilm Released Cells to
Antimicrobials
Surprisingly, released cells from the biofilm in the buffer also
show high recalcitrance to antibiotics in the absence of NO
(<1 log reduction). However, the enhanced efficacy from the
combination of NO and BD-2 and other antibiotics against these
cells in the buffer is still very evident. As shown in Figure 5, a total
of 4 log reduction was observed for the combination of BD-2 and
NO release in 3 h.
The efficacy of the other antibiotics is also generally improved
by NO release. Colistin combined with NO yielded a 5 log
reduction of the biofilm released cells in the buffer (see
Figure 5). For gentamicin, chloramphenicol and ciprofloxacin,
the reduction was >2 log in the presence of NO. The enhancing
effect from the combination of NO and antibiotic was again
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FIGURE 5 | Efficacy of 3 h treatment of BD-2 and antibiotics against
7-day P. aeruginosa biofilm released cells in PBS in the absence and
presence of NO release. The concentration of BD-2 is 20 µg/mL, and
concentration for all other antibiotics is 100 µg/mL. NO flux is 1.5. Asterisk
denotes statistical significance compared with the control samples (n = 3
catheters for treatment, n.s., no significance, ∗p < 0.05; ∗∗p < 0.01).
confirmed by the significant difference (>1 log) between the log
reduction of viable cells from combined treatment and the sum of
that from individual treatment with p< 0.01 for BD-2 and all the
antibiotic tested except for tetracycline. Similarly, the antibiotics
act in a dose-response manner in the presence of NO.
DISCUSSION
Numerous of strategies have been developed for controlling
biofilm on medical devices. Ideally, preventing biofilm formation
would be a more logical option than treating it (Simões et al.,
2010). However, in the clinical setting, biofilm disruption or
removal, though notoriously difficult, is as important as biofilm
prevention since patients cannot take medication in perpetuity
to avoid biofilm formation. In this study, we first established
the dosage effect of physiological levels of NO on pre-formed
biofilms. Further, the effectiveness of NO with an endogenous
antimicrobial peptide and other classical antibiotics in killing
biofilms was evaluated. Our results show that NO release at
physiological fluxes is effective in reducing pre-formed biofilms;
moreover, the used of NO in combination with antimicrobial
agents, including antimicrobial peptide and antibiotics, yields
an enhancing killing effect. This confirms our hypothesis that
physiological levels of NO have the capacity of killing/dispersing
pre-developed mature biofilms, and the NO-dispersed cells are
more susceptible to antimicrobial peptides or antibiotic. This
result is encouraging as it indicates that the function of NO
release is not limited to dispersal or killing of biofilms: NO release
can render the bacteria more susceptible to the host defense
system and to conventional antibiotic treatment.
One finding from this study is that biofilm cells dispersed
from the biofilm matrix into the ambient environment have
different properties from their planktonic form in terms of
antibiotic susceptibility. Those dispersed cells show stronger
recalcitrance to antimicrobial agents than planktonic cells. This
result suggests that for the biofilm-associated infections in
hospitals, the challenge might not be just the biofilm themselves.
Although, we currently do not know whether this property is
inheritable or only temporarily displayed, these highly drug-
resistant cells dispersed from the biofilms deserve additional
attention, as they may circulate and grow inside the body, causing
secondary or systemic infections while being far less sensitive to
traditional antibiotic treatment. In this study, interestingly, we
found that if these detached cells were dispersed by NO from
the biofilm matrix or exposed to NO, their drug-resistance is
greatly attenuated (Figure 5). These data strongly support our
hypothesis that by using NO to disperse biofilm cells and then
using a conventional antimicrobial agent method, these floating
FIGURE 6 | Representative images of P. aeruginosa biofilm released cells staining with Live/Dead BacLightTM Bacterial Viability kit (L7012,
ThermoFisher Scientific, Waltham, MA, USA). Biofilm released cells were stained with two fluorescent dyes, SYTO-9 and propidium iodide (PI), according to its
instructions. Bacterial cells with intact membrane stain with SYTO-9 showing green fluorescent light, while cells with impaired membrane stain with PI showing red
fluorescent light. (A) Bacteria with no NO release treatment; (B) Bacteria with 3 h NO release treatment; (C) Summary of the percentage of permeable cells (red
fluorescence), error bars indicate the standard deviation of measurements from different images. The scale bars in (A,B) are 20 µm.
Frontiers in Microbiology | www.frontiersin.org 6 August 2016 | Volume 7 | Article 1260
fmicb-07-01260 August 17, 2016 Time: 11:0 # 7
Ren et al. Combination of NO/Antimicrobials on P. aeruginosa Biofilms
cells can be killed more effectively. Moreover, synergy was
observed between NO and antibiotics against both biofilm and
planktonic cells, suggesting that NO release from an implanted
medical device at physiological levels is a safe and promising
means of controlling the challenging problem of biofilms on
such devices. Indeed, the local release of physiological levels of
NO on indwelling medical devices could potentially decrease the
length of treatment as well as the dosage of antibiotics required
for successful treatment of device-related infections, offering
a potential solution to the clinical crisis of biofilm-associated
infections.
The combination of antibiotic and NO against bacteria has
been tested and showed a promising result (Reffuveille et al.,
2015). But the mechanism of synergy between NO and antibiotics
on killing drug-sensitive/resistant bacteria in such a short time
period is not entirely clear yet. The combined effects of NO with
colistin, BD-2, chloramphenicol, or gentamicin are stronger than
that of NO with other antibiotics. Colistin and BD-2 have similar
mechanisms of action; they both interact with the bacterial
membrane. Resistance to chloramphenicol and gentamicin is
greatly impacted by bacterial membrane permeability (Mingeot-
Leclercq et al., 1999; Delcour, 2009). Therefore, it is likely that in
addition to dispersing the biofilms, NO changes the permeability
of the bacterial membranes, resulting in more uptake of the
antimicrobial agents. Our data suggest a 58% increase in cells
with damaged membranes when these biofilm-released bacteria
are subjected to NO release for 3 h (see Figure 6).
The effect observed from the electrochemical NO release
system employed here should be differentiated from the
bioelectric effect. A bioelectric effect requires bacteria
experiencing an electric field of 1–20 V/cm when the bacteria
directly contact the electrodes (Costerton et al., 1994; Del Pozo
et al., 2008). In our system, in contrast, the biofilms are insulated
by the relatively thick silicone rubber wall of the catheter and the
electric field is no greater than the typical ambient electric field
in most laboratories (Nair et al., 1989). The absence of significant
bioelectric effect was also experimentally confirmed by similar
biofilms formed on the surface (109 CFU/mL) of a catheter-type
electrochemical O2 sensor, which passes similar levels of current
(several µA) but generates no NO.
It should be noted that the biofilms examined in this study
were grown in the biofilm reactor in vitro using P. aeruginosa
as a model. P. aeruginosa biofilm, a major cause of catheter
associated urinary tract infections (CAUTIs) and pneumonia
in hospitals, has significant clinical relevance (Jones, 2010;
Sievert et al., 2013). Even though it has been reported that
P. aeruginosa bears NO reductase that could neutralize the
effect of NO (Kakishima et al., 2007), in our experiments, we
found that physiological levels of NO still yielded a significant
antimicrobial effect. The results warrant continuous examination
of our hypothesis on different clinical pathogenic organisms,
especially “ESKAPE” (Enterococcus faecium, Staphylococcus
aureus, Klebsiella pneumoniae, Acinetobacter, P. aeruginosa, and
Enterobacter) pathogens, which is necessary to demonstrate
the wide applicability of our test system against microbes
most often associated with common hospital-acquired infections
(Rice, 2010). Further studies employing animal models are
also warranted to demonstrate the applicability of the system
in clinical settings for control of biofilm-related infections on
intravascular and urinary catheters.
In summary, the precise control of the electrochemical NO
release from a catheter tubing surface can provide a powerful
tool to conduct fundamental studies on the true effect of
NO on bacteria and their biofilms. Dosage studies revealed a
significant killing effect on biofilms by NO at physiological fluxes
(>0.5 × 10−10 mol cm−2 min−1). Such NO release also exhibits
synergy with both endogenous antimicrobial peptides and
various common antibiotics against biofilm and biofilm released
cells. Such a combination therapy of using NO release with
existing antibiotics should provide a promising new treatment
approach for medical device-related infections.
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